journal article Jan 01, 2021

CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer

Tongyuan Deng Peng Shen

Huiling Yang Xiaojie Deng Xuemei Peng Zhe Hu

Zibo Tang Jiahao Liu

Rentao Hou Zhen Liu

Theranostics Vol. 11 No. 16 pp. 8112-8128 · Ivyspring International Publisher

View at Publisher Save 10.7150/thno.54961

Topics

No keywords indexed for this article. Browse by subject →

Cited By

52

Role of ENO1 and its targeted therapy in tumors

Lu Liu, Bo Li · 2024

Journal of Translational Medicine

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy

Yuanzhuo Gu, Zhengkui Zhang · 2023

Cellular & Molecular Immunology

Metrics

52

Citations

0

References

Details

Published: Jan 01, 2021
Vol/Issue: 11(16)
Pages: 8112-8128

Authors

Department of Gastroenterology; Huai'an First People's Hospital; Nanjing Medical University; Huai'an; P. R. China

Cite This Article

Tongyuan Deng, Peng Shen, Aimin Li, et al. (2021). CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics, 11(16), 8112-8128. https://doi.org/10.7150/thno.54961

Related

You May Also Like

Ultrasound Elastography: Review of Techniques and Clinical Applications

Rosa M.S. Sigrist, Joy Liau · 2017

1,575 citations

Engineering exosomes for targeted drug delivery

Li Duan, Jianping Lu · 2021

1,335 citations

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics

Lili Zou, Hong Wang · 2016

839 citations

The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges

Zhenyu Liu, Shuo Wang · 2019

836 citations

Platinum-based drugs for cancer therapy and anti-tumor strategies

Chunyu Zhang, Chao Xu · 2022

834 citations